Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 8;15(11):e48507.
doi: 10.7759/cureus.48507. eCollection 2023 Nov.

Amiodarone and Adenosine for Pediatric Supraventricular Tachycardia: A Systematic Review

Hector I Guerra Toro  1 , Arturo P Jaramillo  2 , Valeria M Caceres  3 , Genesis Pazmino  4
Affiliations
Review

Amiodarone and Adenosine for Pediatric Supraventricular Tachycardia: A Systematic Review

Hector I Guerra Toro et al. Cureus. .

Abstract

A review of the literature was made to find and choose research papers, on drugs (amiodarone and adenosine) used for managing supraventricular tachycardia (SVT) in children and infants (one hour to 17 years of age) with no structural heart disease by PRISMA guideline. Our team conducted an exhaustive systematic literature review (SLR), utilizing an extensive search methodology across recognized databases like PubMed, PubMed Central, Google Scholar, Web of Science, and The Cochrane Library. We included 10 scholarly articles that satisfied our rigorous selection criteria including systematic reviews/meta-analysis, and randomized control trials, shedding light on treatment with amiodarone and adenosine for SVT in pediatric patients. There is no first- or second-line treatment for SVT in pediatrics, and drug effectiveness can vary significantly between patients. Adenosine has a shorter half-life than other drugs, instead, it is safer and more valuable when an electrocardiogram is uncertain, it is recommended as an acute management, and it continues as the first-line option for paroxysmal SVT. Amiodarone management patients with acute STV within, its use showed better results when administered 48 hours after diagnosis. Furthermore, it is recommended to reduce the incidence of junctional ectopic tachycardia (JET), by pre-operative prophylaxis, also for chronic control in this and other types of SVT. In none of the evaluated studies were documented significant adverse effects in pediatric patients. Side effects that did occur were mild and easily managed. The studies also emphasize that although both amiodarone and adenosine can successfully convert SVT to sinus rhythm, better results have been observed when using combined therapies of each recommended medication. Therefore, more randomized clinical trials, meta-analyses, and systematic reviews are needed to solidify and possibly standardize an effective and safe pharmacological treatment for SVT and its types in pediatric patients.

Keywords: adenosine; amiodarone; drug therapeutics; supraventricular tachycardia; pediatric.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. PRISMA flow diagram
See this image and copyright information in PMC

References

    1. A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children. Hill AC, Silka MJ, Bar-Cohen Y. Pacing Clin Electrophysiol. 2019;42:670–677. - PubMed
    1. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: Developed in partnership with the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC) Philip Saul J, Kanter RJ, Abrams D, et al. Heart Rhythm. 2016;13:0–89. - PubMed
    1. Emergency diagnosis and management of pediatric arrhythmias. Hanash CR, Crosson JE. J Emerg Trauma Shock. 2010;3:251–260. - PMC - PubMed
    1. Ivabradine versus amiodarone in the management of postoperative junctional ectopic tachycardia: a randomized, open-label, noninferiority study. Arvind B, Kothari SS, Juneja R, et al. JACC Clin Electrophysiol. 2021;7:1052–1060. - PubMed
    1. Diagnosis and management of common types of supraventricular tachycardia. Helton MR. https://pubmed.ncbi.nlm.nih.gov/26554472/ Am Fam Physician. 2015;92:793–800. - PubMed

LinkOut - more resources